SavedAdd your journal

Journals / Adıyaman Üniversitesi Fen Bilimleri Dergisi / 2019 / Cilt: 9 - Sayı: 2

Complexation Energies and Electronic-Structural Properties of Adamantane Derivatives: A DFT Study

Adamantan Türevlerinin Kompleksleşme Enerjileri ve Elektronik-Yapısal Özellikleri: Bir DFT Çalışması

Mustafa KARAKAYA
Pages
290–302
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, the images mapped with total density and electrostatic potential have been obtained in this study.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This article is an investigation related to the complexation energies, binding abilities, frontier molecular orbital’s energy gaps and dipole moments on dimeric forms of 1-adamantanol, 1-adamantanemethylamine and 1-adamantanecarboxylic acid as the adamantane derivatives.
📊
Key Findings & Data:All the optimizations, counterpoise corrections and complexation energy computations have been achieved by density functional theory with B3LYP and WB97XD functionals.
💡
Conclusion & Impact:In addition, the images mapped with total density and electrostatic potential have been obtained in this study.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

This article is an investigation related to the complexation energies, binding abilities, frontier molecular orbital’s energy gaps and dipole moments on dimeric forms of 1-adamantanol, 1-adamantanemethylamine and 1-adamantanecarboxylic acid as the adamantane derivatives. All the optimizations, counterpoise corrections and complexation energy computations have been achieved by density functional theory with B3LYP and WB97XD functionals. In all counterpoise calculations have been used the empirical dispersion method with B3LYP and WB97XD for non-covalent interactions. The more favorable complexation energies have been obtained by B3LYP with the addition of dispersion correction. In addition, the images mapped with total density and electrostatic potential have been obtained in this study.

Özet

Bu makale, adamantan türevleri olarak 1-adamantanol, 1-adamantanmetilamin ve 1-adamantankarboksilik asit yapılarının dimerik formlarında kompleksleşme enerjileri, bağlanma yetenekleri, sınır moleküler orbital enerji boşlukları ve dipol momentleri ile ilgilidir. Tüm optimizasyonlar, counterpoise düzeltmeleri ve kompleksleşme enerji hesaplamaları, B3LYP ve WB97XD ile yoğunluk fonksiyonel teorisi yardımıyla elde edilmiştir. Tüm counterpoise hesaplamalarında kovalent olmayan etkileşimler için B3LYP ve WB97XD ile ampirik dispersiyon metodu kullanılmıştır. B3LYP yaklaşımında dispersiyon düzeltmesinin eklenmesiyle daha uygun kompleksleşme enerjileri elde edilmiştir. Ek olarak, bu çalışmada toplam yoğunluk ve elektrostatik potansiyel ile haritalanan görüntüler elde edilmiştir.

🔖

Cite This Article

KARAKAYA, M. (2022). Complexation Energies and Electronic-Structural Properties of Adamantane Derivatives: A DFT Study. Adıyaman Üniversitesi Fen Bilimleri Dergisi, Cilt: 9 - Sayı: 2, 290–302. https://ajindex.com/articles/428469

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Shundalau, M.B., Al-Abdullah, E.S., Shabunya-Klyachkovskaya, E.V., Hlinisty, A.V., Al-Deeb, O.A., El-Emam, A.A., Gaponenko, S.V., Raman, infrared and DFT studies of N'-(adamantan-2-ylidene) benzohydrazide, a potential antibacterial agent, Journal of Molecular Structure, 1115, 258-266, 2016
  2. Lamoureux G., Artavia G., Use of the adamantane structure in medicinal chemistry, Current Medicinal Chemistry, 17, 2967-2978, 2010
  3. Liu, J., Obando, D., Liao, V., Lifa, T., Codd, R., The many faces of the adamantly group in drug design, European Journal of Medicinal Chemistry, 46, 1949-1963, 2011
  4. Al-Wahaibi, L.H., Hassan, H.M., Abo-Kamar, A.M., Ghabbour, H.A. and El-Emam, A.A., Adamantane-ısothiourea hybrid derivatives:synthesis, characterization, in vitro antimicrobial, and in vivo hypoglycemic activities, Molecules, 22, 710, 2017
  5. Davies, W.L., Grunnert, R.R., Haff, R.F., McGahen, J.W., Neumeyer, E.M., Paulshock, M., Watts, J.C., Wood, T.R., Hermann, E.C., Hoffmann, C.E., Antiviral activity of 1-adamantamine (amantadine), Science, 144, 862–863, 1964
  6. Togo, Y., Hornick, R.B., Dawkins, A.T., Studies on induced influenza in man: I. double blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against A2/Rockville/1/65 strain, Journal of the American Medical Association, 203, 1089–1094, 1968
  7. Wendel, H.A., Snyder, M.T., Pell, S., Trial of amantadine in epidemic influenza, Journal of Clinical Pharmacy and Therapeutics, 7, 38–43, 1966
  8. Schwab, R.S., England, A.C., Poskanzer, D.C., Young, R.R., Amantadine in the treatment of Parkinson’s disease, Journal of the American Medical Association, 208, 1168–1170, 1969
  9. Sun, S.Y., Yue, P., Chen, X., Hong, W.K., Lotan, R., The synthetic retinoid CD437 selectively induces apoptosis in human lung cancer cells while sparing normal human lung epithelial cells, Cancer Research, 62, 2430-2436, 2002
  10. Nakamura, Y., Fujimoto, T., Ogawa, Y., Namiki, H., Suzuki, S., Asano, M., Sugita, C., Mochizuki, A., Miyazaki, S., Tamaki, K., Nagai, Y., Inoue, S., Nagayama, T., Kato, M., Chiba, K., Takasuna, K., Nishi, T., Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: discovery of DS-8108b, an orally active renin inhibitor, Bioorganic & Medicinal Chemistry, 21, 3175-3196, 2013
  11. Abou-Gharbia, M. A., Childers, W. E., Fletcher, H., McGaughey, G., Patel, U., Webb, M. B., Yardley, J., Andree, T., Boast, C.,